Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Thomas Roshek

Surgery Plano, TX Medical Doctor

NPI 1649497629 CMS profile 301412

5000 Legacy Dr Ste 200, Plano, TX 75024

Open in the dashboard

General payments

$29,681

181 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Thomas Roshek of Plano, TX is reported in the CMS Open Payments database as having received $29,681 across 181 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $16,095 55
2024 General $2,455 25
2023 General $1,450 16
2022 General $2,327 24
2021 General $26 2
2020 General $294 3
2019 General $7,035 56

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Thomas Roshek
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Thomas Roshek were reported at $16,095. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Thomas Roshek Surgery median Middle half National median
2019 $7,035 $253 $82–$1,521 $163
2020 $294 $131 $40–$706 $114
2021 $26 $168 $50–$904 $132
2022 $2,327 $224 $76–$1,218 $149
2023 $1,450 $253 $82–$1,255 $160
2024 $2,455 $279 $90–$1,381 $164
2025 $16,095 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $10,496 53 payments
  2. Ethicon Inc. $8,177 6 payments
  3. Medtronic, Inc. $6,093 67 payments
  4. W. L. Gore & Associates, Inc. $2,728 24 payments
  5. Covidien LP $1,077 13 payments
  6. Ethicon US, LLC $518 9 payments
  7. Medical Device Business Services, Inc. $430 4 payments
  8. Tepha Inc $87 1 payment
  9. Endo Pharmaceuticals Inc. $34 2 payments
  10. Apollo Endosurgery US Inc $23 1 payment
  11. Other $19 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $11,535 60 payments
  2. Food and Beverage $6,733 115 payments
  3. Consulting Fee $6,580 1 payment
  4. Education $4,833 5 payments
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $7,246 51 payments
  2. DAVINCI XI $3,250 2 payments
  3. Signia $3,024 33 payments
  4. LigaSure $2,808 25 payments
  5. BIO-A Tissue Reinforcement $1,295 8 payments
  6. SEAMGUARD Bioabsorbable Staple Line Reinforcement $780 4 payments
  7. iDrive $296 1 payment
  8. GORE SEAMGUARD Bioabsorbable Staple Line Reinforce $295 3 payments
  9. Sonicision $271 3 payments
  10. LINX Reflux Management System $261 2 payments
  11. Other $1,546 41 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

181 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record